These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 26282787

  • 1. MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
    Chiang KC, Kuo SF, Chen CH, Ng S, Lin SF, Yeh CN, Chen LW, Takano M, Chen TC, Juang HH, Kittaka A, Lin JD, Pang JH.
    Cancer Lett; 2015 Dec 01; 369(1):76-85. PubMed ID: 26282787
    [Abstract] [Full Text] [Related]

  • 2. MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
    Chiang KC, Chen SC, Yeh CN, Pang JH, Shen SC, Hsu JT, Liu YY, Chen LW, Kuo SF, Takano M, Kittaka A, Sun CC, Juang HH, Chen TC.
    J Steroid Biochem Mol Biol; 2014 Jan 01; 139():54-60. PubMed ID: 24125734
    [Abstract] [Full Text] [Related]

  • 3. MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
    Yang SW, Tsai CY, Pan YC, Yeh CN, Pang JH, Takano M, Kittaka A, Juang HH, Chen TC, Chiang KC.
    Drug Des Devel Ther; 2016 Jan 01; 10():1995-2002. PubMed ID: 27382252
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.
    Chiang KC, Yeh CN, Hsu JT, Jan YY, Chen LW, Kuo SF, Takano M, Kittaka A, Chen TC, Chen WT, Pang JH, Yeh TS, Juang HH.
    Cancer Lett; 2014 Nov 28; 354(2):235-44. PubMed ID: 25149065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
    Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, Sun CC, Huang CC, Pang JH, Flanagan JN, Takano M, Kittaka A, Juang HH, Yang SW, Chen TC.
    J Steroid Biochem Mol Biol; 2013 Nov 28; 138():427-34. PubMed ID: 24044969
    [Abstract] [Full Text] [Related]

  • 8. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.
    Chiang KC, Yeh CN, Pang JS, Hsu JT, Yeh TS, Chen LW, Kuo SF, Takano M, Chen TC, Kittaka A, Hsieh PJ, Juang HH.
    Anticancer Res; 2017 Nov 28; 37(11):6215-6221. PubMed ID: 29061804
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
    Flanagan JN, Zheng S, Chiang KC, Kittaka A, Sakaki T, Nakabayashi S, Zhao X, Spanjaard RA, Persons KS, Mathieu JS, Holick MF, Chen TC.
    Anticancer Res; 2009 Sep 28; 29(9):3547-53. PubMed ID: 19667147
    [Abstract] [Full Text] [Related]

  • 10. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells.
    Chiang KC, Yeh CN, Chen HY, Lee JM, Juang HH, Chen MF, Takano M, Kittaka A, Chen TC.
    Steroids; 2011 Dec 11; 76(13):1513-9. PubMed ID: 21888924
    [Abstract] [Full Text] [Related]

  • 11. MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression.
    Chiang KC, Yeh CN, Yeh TS, Juang HH, Chen LW, Kuo SF, Chen MH, Chen TC, Takano M, Kittaka A, Pang JS.
    Anticancer Res; 2018 Jul 11; 38(7):3879-3887. PubMed ID: 29970508
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the potential therapeutic role of a new generation of vitamin D analog, MART-10, in human pancreatic cancer cells in vitro and in vivo.
    Chiang KC, Yeh CN, Hsu JT, Yeh TS, Jan YY, Wu CT, Chen HY, Jwo SC, Takano M, Kittaka A, Juang HH, Chen TC.
    Cell Cycle; 2013 Apr 15; 12(8):1316-25. PubMed ID: 23549173
    [Abstract] [Full Text] [Related]

  • 13. 19-Norvitamin D analogs for breast cancer therapy.
    Matsumoto Y, Kittaka A, Chen TC.
    Can J Physiol Pharmacol; 2015 May 15; 93(5):333-48. PubMed ID: 25918960
    [Abstract] [Full Text] [Related]

  • 14. MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
    Chiang KC, Yeh TS, Huang CC, Chang YC, Juang HH, Cheng CT, Pang JS, Hsu JT, Takano M, Chen TC, Kittaka A, Hsiao M, Yeh CN.
    Sci Rep; 2017 Mar 03; 7():43773. PubMed ID: 28256614
    [Abstract] [Full Text] [Related]

  • 15. Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.
    Iglesias-Gato D, Zheng S, Flanagan JN, Jiang L, Kittaka A, Sakaki T, Yamamoto K, Itoh T, Lebrasseur NK, Norstedt G, Chen TC.
    J Steroid Biochem Mol Biol; 2011 Nov 03; 127(3-5):269-75. PubMed ID: 21911059
    [Abstract] [Full Text] [Related]

  • 16. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells.
    Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, Wang X, Pan Y, Liu Y, Wang P.
    Biochem Biophys Res Commun; 2011 Nov 03; 468(1-2):130-5. PubMed ID: 26523511
    [Abstract] [Full Text] [Related]

  • 17. 1α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
    Chiang KC, Yeh CN, Pang JH, Hsu JT, Yeh TS, Chen LW, Kuo SF, Hsieh PJ, Pan YC, Takano M, Chen TC, Feng TH, Kittaka A, Juang HH.
    Anticancer Res; 2016 Jul 03; 36(7):3307-13. PubMed ID: 27354587
    [Abstract] [Full Text] [Related]

  • 18. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jul 03; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 19. 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition.
    Hou YF, Gao SH, Wang P, Zhang HM, Liu LZ, Ye MX, Zhou GM, Zhang ZL, Li BY.
    Int J Mol Sci; 2016 Aug 19; 17(8):. PubMed ID: 27548154
    [Abstract] [Full Text] [Related]

  • 20. CYP24A1 as a potential target for cancer therapy.
    Sakaki T, Yasuda K, Kittaka A, Yamamoto K, Chen TC.
    Anticancer Agents Med Chem; 2014 Jan 19; 14(1):97-108. PubMed ID: 23869781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.